Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2026-02-03 @ 2:21 AM
Study NCT ID:
NCT03366103
Status:
TERMINATED
Last Update Posted:
2023-10-17
First Post:
2017-12-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Malignant Solid Neoplasm | View |
| None | Recurrent Lung Small Cell Carcinoma | View |
| None | Recurrent Malignant Solid Neoplasm | View |
| None | Refractory Malignant Solid Neoplasm | View |
| None | Stage III Lung Small Cell Carcinoma, by American Joint Committee … | View |
| None | Stage IIIA Lung Small Cell Carcinoma AJCC v7 | View |
| None | Stage IIIB Lung Small Cell Carcinoma AJCC v7 | View |
| None | Stage IV Lung Small Cell Carcinoma AJCC v7 | View |
| None | Unresectable Solid Neoplasm | View |
Keywords: